These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
99 related articles for article (PubMed ID: 3364359)
1. Use dependence of amiodarone during the sinus tachycardia of exercise in coronary artery disease. Cascio WE; Woelfel A; Knisley SB; Buchanan JW; Foster JR; Gettes LS Am J Cardiol; 1988 May; 61(13):1042-5. PubMed ID: 3364359 [TBL] [Abstract][Full Text] [Related]
2. Use-dependent electrophysiologic effects of amiodarone in coronary artery disease and inducible ventricular tachycardia. Chiamvimonvat N; Mitchell LB; Gillis AM; Wyse DG; Sheldon RS; Duff HJ Am J Cardiol; 1992 Sep; 70(6):598-604. PubMed ID: 1324598 [TBL] [Abstract][Full Text] [Related]
3. The effect of intravenous amiodarone on heart rate in patients with acute myocardial infarction or ischemia and sinus tachycardia. Kusniec J; Strasberg B; Sclarovsky S; Klainman E; Agmon J Chest; 1988 Sep; 94(3):584-8. PubMed ID: 3409740 [TBL] [Abstract][Full Text] [Related]
4. Comparison of electrophysiologic effects of quinidine and amiodarone in sustained ventricular tachyarrhythmias associated with coronary artery disease. Pastor A; Almendral JM; Arenal A; Lorca MT; Delcán JL Am J Cardiol; 1993 Dec; 72(18):1389-94. PubMed ID: 8256732 [TBL] [Abstract][Full Text] [Related]
5. Acute and chronic effects of amiodarone on ventricular refractoriness, intraventricular conduction and ventricular tachycardia induction. Morady F; DiCarlo LA; Krol RB; Baerman JM; de Buitleir M J Am Coll Cardiol; 1986 Jan; 7(1):148-57. PubMed ID: 3941203 [TBL] [Abstract][Full Text] [Related]
6. Effects of intravenous amiodarone on ventricular refractoriness, intraventricular conduction, and ventricular tachycardia induction. Kułakowski P; Karczmarewicz S; Karpiński G; Soszyńska M; Ceremuzyński L Europace; 2000 Jul; 2(3):207-15. PubMed ID: 11227590 [TBL] [Abstract][Full Text] [Related]
7. Amplification of flecainide-induced ventricular conduction slowing by exercise. A potentially significant clinical consequence of use-dependent sodium channel blockade. Ranger S; Talajic M; Lemery R; Roy D; Nattel S Circulation; 1989 May; 79(5):1000-6. PubMed ID: 2540920 [TBL] [Abstract][Full Text] [Related]
8. Comparison of individual and combined effects of procainamide and amiodarone in patients with sustained ventricular tachyarrhythmias. Marchlinski FE; Buxton AE; Kindwall KE; Miller JM; Rosenthal ME; Gottlieb CD; Bloom RB; Josephson ME Circulation; 1988 Sep; 78(3):583-91. PubMed ID: 3409498 [TBL] [Abstract][Full Text] [Related]
9. Rate-dependent effects of intravenous lidocaine, procainamide and amiodarone on intraventricular conduction. Morady F; DiCarlo LA; Baerman JM; Krol RB J Am Coll Cardiol; 1985 Jul; 6(1):179-85. PubMed ID: 4008772 [TBL] [Abstract][Full Text] [Related]
10. Magnitude and time course of beta-adrenergic antagonism during oral amiodarone therapy. Kadish AH; Chen RF; Schmaltz S; Morady F J Am Coll Cardiol; 1990 Nov; 16(5):1240-5. PubMed ID: 1699982 [TBL] [Abstract][Full Text] [Related]
11. The effects of allitridi and amiodarone on the conduction system and reverse use-dependence in the isolated hearts of rats with myocardial infarction. Xing Y; Chen J; Wang J; Gao Y; Niu W; Zhao M; Zhu H; Guo L; Lu P; Wang S J Ethnopharmacol; 2012 Jun; 141(2):674-84. PubMed ID: 21924334 [TBL] [Abstract][Full Text] [Related]
12. Effects of flecainide on exercise hemodynamics and electrocardiography in patients without structural heart disease. Wang JA; Lau CP; Tai YT; Wu BZ Clin Cardiol; 1995 Mar; 18(3):140-4. PubMed ID: 7743684 [TBL] [Abstract][Full Text] [Related]
14. Effect of amiodarone on retrograde conduction and refractoriness of the His-Purkinje system in man. Reddy CP; Kuo CS Br Heart J; 1984 Jun; 51(6):648-53. PubMed ID: 6732994 [TBL] [Abstract][Full Text] [Related]
16. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study. Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357 [TBL] [Abstract][Full Text] [Related]
17. Clinical efficacy and electropharmacology of continuous intravenous amiodarone infusion and chronic oral amiodarone in refractory ventricular tachycardia. Saksena S; Rothbart ST; Shah Y; Cappello G Am J Cardiol; 1984 Aug; 54(3):347-52. PubMed ID: 6465016 [TBL] [Abstract][Full Text] [Related]
18. Clinical efficacy of ivabradine in patients with inappropriate sinus tachycardia: a prospective, randomized, placebo-controlled, double-blind, crossover evaluation. Cappato R; Castelvecchio S; Ricci C; Bianco E; Vitali-Serdoz L; Gnecchi-Ruscone T; Pittalis M; De Ambroggi L; Baruscotti M; Gaeta M; Furlanello F; Di Francesco D; Lupo PP J Am Coll Cardiol; 2012 Oct; 60(15):1323-9. PubMed ID: 22981555 [TBL] [Abstract][Full Text] [Related]
19. Tachydysrhythmias. Stahmer SA; Cowan R Emerg Med Clin North Am; 2006 Feb; 24(1):11-40, v-vi. PubMed ID: 16308111 [TBL] [Abstract][Full Text] [Related]
20. Amiodarone is poorly effective for the acute termination of ventricular tachycardia. Marill KA; deSouza IS; Nishijima DK; Stair TO; Setnik GS; Ruskin JN Ann Emerg Med; 2006 Mar; 47(3):217-24. PubMed ID: 16492484 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]